GBM tumor cells assist the recruitment and maintenance of Tregs in the TME by secreting soluble molecules such as CCL22 [165], and the number of Tregs has been shown to have an inverse rapport with patient survival [166]. This evidence concerns the gene CCL22 and glioblastoma.